A Rare Case of Myasthenia Gravis With Underlying Aldolase A Deficiency: Diagnostic and Therapeutic Challenges
Related Experiment Video
Updated: Sep 14, 2025

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
Published on: April 14, 2022
Niyas Khalid Ottu Para1, Divyashri Ramanathan Nagarajan1, Daya Mani Jacob1
1Internal Medicine, Burjeel Medical City, Abu Dhabi, ARE.
Abstract:
We report one of the first documented cases globally of a 24-year-old female presenting with recurrent episodes of muscle pain, weakness, and rhabdomyolysis. Although she initially improved with conservative management, her symptoms recurred, warranting further investigation. Comprehensive serologic and metabolic evaluations revealed a rare dual diagnosis of seropositive myasthenia gravis (MG) and aldolase A deficiency. MG, an autoimmune neuromuscular junction disorder, contributed to her characteristic diurnal fatigue and acetylcholine receptor antibody positivity, while aldolase A deficiency, a rare metabolic myopathy, was responsible for impaired glycolysis and exertional rhabdomyolysis. This case underscores the importance of considering overlapping autoimmune and metabolic neuromuscular conditions in young adults with unexplained muscle breakdown.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Inborn Errors of Metabolism
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...

